View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Pharmatest
11 October 2016

Pharmatest Services Announces the Purchase of New Bone Imaging Equipment

Pharmatest Services has purchased two new devices for bone imaging, the SkyScan 1276 high-resolution desktop in vivo Micro-computed tomography (mCT) system of Bruker and the Faxitron UltraFocus dual-energy X-ray absorptiometry (DXA) digital radiography system of DatecMedico.

Pharmatest Services is a contract research organisation offering preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal disease. Bone imaging has an important role in the services offered by the company.

SkyScan 1276 high-resolution desktop in vivo mCT system of Bruker was launched in September. It addresses the latest needs of preclinical imaging in animal studies by reducing the radiation dose while maintaining highest image quality and spatial resolution.

The Faxitron Ultrafocus DXA digital radiography system of DatecMedico improves the quality and resolution of in vivo X-ray images with an additional option of measuring bone mass density (BMD), bone mineral content (BMC), and lean and fat mass percentages.

CEO of Pharmatest Jussi Halleen comments: "This new equipment will further improve our strong bone imaging capabilities and provide added value to both our skeletal disease and oncology studies. They allow us to offer our customers high-quality follow-up data in rats and mice using latest and most advanced imaging technologies."

4T1 is a triple-negative mouse breast cancer cell line. Pharmatest utilises a 4T1 cell line with stable expression of green fluorescent protein (GFP) enabling easy...
Metastatic and primary tumours are known to respond differently to chemotherapy. Therefore, when establishing drug efficacy it is important not to rely only on experiments...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology